World’s First Personalised mRNA Vaccine for Melanoma Undergoing Trials
The world’s first personalised mRNA vaccine for melanoma, known as mRNA-4157 (V940), developed by Moderna and Merck Sharp & Dohme (MSD), is advancing into Phase…
Diseases
WHO’s New Global Malaria Strategy for 2030
The WHO’s New Global Malaria Strategy for 2030 aims to significantly accelerate efforts to combat malaria, a pervasive global health threat that continues to cause…
Glycemic Index and Load
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Euvichol-S: WHO Approves New Oral Cholera Vaccine
The World Health Organization (WHO) recently approved Euvichol-S, a new oral cholera vaccine developed by EuBiologics Co., Ltd. in South Korea. Euvichol-S simplifies the formulation…
African Swine Fever Outbreak in Kohima
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Men5CV Meningitis Vaccine
The Men5CV vaccine, recently introduced in Nigeria, marks a significant advancement in the global fight against meningitis. This innovative vaccine, known as MenFive, is capable…
Chagas Disease
Chagas disease, caused by the Trypanosoma cruzi parasite and spread by triatomine bugs, is a significant public health concern, particularly in Latin America. World Chagas…
Health of Nation Report
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
The Next Pandemic Nightmare: Are We Ready for Disease X?
Disease X represents a hypothetical, yet unidentified pathogen that could cause a future pandemic, drawing attention from global health leaders and ex…
